Align Technology

ALGN is the ticker symbol for Align Technology, a company classified under the Health Care Supplies industry within the broader Health Care sector.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Key metrics include a return on equity of 2.7%, a debt-to-equity ratio of 0.52.

The company reports trailing twelve-month revenue of $125.89M and net income of $112.77M.

FINOTAUR aggregates real-time and fundamental data on ALGN to help traders and investors make informed decisions. Track ALGN in your trading journal alongside other positions for a unified view of your portfolio.